Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation

Transplantation. 1994 Oct 15;58(7):858-60.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation / immunology*
  • Child
  • Female
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / prevention & control*
  • Haplotypes*
  • Humans
  • Interleukin-2 / therapeutic use*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy

Substances

  • Interleukin-2